Bone mineral density and growth changes in patients with distal renal tubular acidosis after two-years treatment with a new alkalizing drug (ADV7103)

Bertholet-Thomas, Aurélia; Manso-Silván, Maria A; Navas-Serrano, Victor; Guittet, Catherine; Joukoff, Sophie; Bacchetta, Justine; Boyer, Olivia; Rodriguez Portillo, Mariano; Granier, Luc-André.
Nefrología (Madrid) ; 43(4): 458-466, jul.-ago. 2023. tab, graf
Artículo en Inglés | IBECS (España) | ID: ibc-223965

Documentos relacionados

  1. Bone mineral density and growth changes in patients with distal renal tubular acidosis after two-years treatment with a new alkalizing drug (ADV7103).
  2. A velocidade de infusão da solução poli-iônica intravenosa contendo 84mEq/L de lactato determina a intensidade do efeito alcalinizante em equinos
  3. A velocidade de infusão da solução poli-iônica intravenosa contendo 84mEq/L de lactato determina a intensidade do efeito alcalinizante em equinos
  4. Safety, efficacy, and acceptability of ADV7103 during 24 months of treatment: an open-label study in pediatric and adult patients with distal renal tubular acidosis.
  5. Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments.
  6. Efeito alcalinizante de soluções eletrolíticas intravenosas com concentrações elevadas de lactato de sódio infundidas em bezerros sadios
  7. Efectos de la alcalosis metabólica inducida por la dieta en el rendimiento anaeróbico de alta intensidad
  8. Diagnosis and Treatment of Metabolic Acidosis in Patients with Chronic Kidney Disease - Position Statement of the Working Group of the Polish Society of Nephrology.
  9. Diabetic Ketoalkalosis: A Common Yet Easily Overlooked Alkalemic Variant of Diabetic Ketoacidosis Associated with Mixed Acid-Base Disorders.
  10. Recent evidence on the effect of treatment of metabolic acid on the progression of kidney disease.